Inclusion Criteria:  Aged 18 - 70 years Physician diagnosis of Type 2 diabetes Haemoglobin A1c (HbA1c) range between 7 - 10% Body mass index between 20 - 40 Regularly eats 3 meals per day (breakfast, lunch, and dinner) Technologically literate (e.g. able to use Apps, smart phones) Able to commit to attending the Sponsor site Able to commit to wearing a non-invasive, custom-built device through most daily activities Currently self-monitoring their BGL and able to commit to taking measurements at least 6 times per day Proficiency in reading and writing in English  Exclusion Criteria:  Currently on insulin therapy (other than long-acting insulin therapy) Currently pregnant, pregnant in the last 6 months, or planning a pregnancy Currently breastfeeding Current smoker Any other confounding major disease or condition as deemed appropriate by investigator, determined by review of medical history and/or patient reported medical history Clinically unstable or rapidly progressing diabetic retinopathy, neuropathy, and/or frequent nausea, bloating or vomiting, sever gastroesophageal reflux, or early satiety. Multiple medications (taking more than 10 medications is often an indicator of having multiple major comorbidities which is an exclusion criteria. Furthermore, we want to exclude potential multiple drug interactions with blood glucose levels which may impact results of study) Currently on active curative treatments for cancer Currently receiving systemic glucocorticoid therapy Using lipid-lowering medication at a dose that has not been stable for the past 3 months History of reactions to alcohol wipes, antiseptics, or adhesives (isobornyl acrylate which is the adhesive used for attachment of Freestyle Libre sensors and may cause contact dermatitis) Using an insulin pump Pacemaker fitted Fasting C-peptide levels below 0.5 ng/mL or above 2.0 ng/mL Has had an episode of diabetic ketoacidosis in the past 6 months Has had an episode of severe hypoglycemia within the past 6 months Currently unstable blood glucose control Receiving dialysis treatment Has had a blood transfusion or severe blood loss within the past 3 months Unwilling to self-monitor their BGL (at least 6 measurement, daily) Currently participating in another clinical study Known to the Investigators Other investigator-determined criteria making participants unsuitable for participation